Insiders bought 212K and sold 306K on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. CFO and Interim President Joshua S. Lev sold 200K on Aug 25, 19% of their stake, outside a plan.
Get an email when ECOR's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14 | Thomas J. Errico Director | Bought | 5,000 | $9.82 | 49K | 1.4% | Form 4 |
| Sep 11 | Michael Fox See Remarks | Bought | 5,000 | $9.80 | 49K | 4.0% | Form 4 |
| Aug 21 – 25 | Joshua S. Lev CFO and Interim President | SoldNo plan 3 parts | 20,000 | $10.01 average | 200K | 19% | Form 4 |
| Aug 13 | Thomas J. Errico Director | Bought | 5,000 | $9.85 | 49K | 1.5% | Form 4 |
| May 28 | Joshua S. Lev CFO and Interim President | SoldNo plan | 6,667 | $9.00 | 60K | 7.3% | Form 4 |
| May 22 | Joshua S. Lev CFO and Interim President | SoldNo plan | 3,000 | $6.50 | 20K | 3.2% | Form 4 |
| May 21 | Thomas J. Errico Director | Bought | 9,992 | $5.99 | 60K | 2.9% | Form 4 |
| Apr 23 | Daniel S Goldberger Other | SoldNo plan | 80,000 | $6.80 | 544K | 27% | Form 4 |
| Apr 10 | Daniel S Goldberger Other | SoldNo plan | 16,072 | $6.02 | 97K | 5.2% | Form 4 |
| Dec 4, 2025 | Joshua S. Lev Chief Financial Officer | SoldNo plan | 2,500 | $5.05 | 13K | 10% | Form 4 |
| Dec 2, 2025 | Daniel S Goldberger Chief Executive Officer | Bought | 1,000 | $4.84 | 5K | 0.3% | Form 4 |
| Nov 12, 2025 | Joshua S. Lev Chief Financial Officer | SoldNo plan | 2,166 | $6.18 | 13K | 8.4% | Form 4 |
| Aug 11, 2025 | Thomas J. Errico Director | Bought | 15,000 | $4.47 | 67K | 5.6% | Form 4 |
| Aug 11, 2025 | Daniel S Goldberger Chief Executive Officer | Bought | 1,000 | $4.23 | 4K | 0.3% | Form 4 |
| May 23, 2025 | John P Gandolfo Director | Bought | 1,800 | $5.01 | 9K | 2.7% | Form 4 |
| May 12, 2025 | Thomas J. Errico Director | Bought | 10,000 | $4.77 | 48K | 3.9% | Form 4 |
| Mar 17, 2025 | Daniel S Goldberger Chief Executive Officer | Bought | 1,000 | $8.59 | 9K | 0.3% | Form 4 |
| Mar 17, 2025 | Thomas J. Errico Director | Bought | 6,000 | $8.10 | 49K | 2.4% | Form 4 |
- Sep 14Thomas J. ErricoDirector · bought 5,000 at $9.8249K1.4% of stake
- Sep 11Michael FoxSee Remarks · bought 5,000 at $9.8049K4.0% of stake
- Aug 21 – 25No planJoshua S. LevCFO and Interim President · sold 20,000 at avg $10.01200K19% of stake
- Aug 13Thomas J. ErricoDirector · bought 5,000 at $9.8549K1.5% of stake
- May 28No planJoshua S. LevCFO and Interim President · sold 6,667 at $9.0060K7.3% of stake
- May 22No planJoshua S. LevCFO and Interim President · sold 3,000 at $6.5020K3.2% of stake
- May 21Thomas J. ErricoDirector · bought 9,992 at $5.9960K2.9% of stake
- Apr 23No planDaniel S GoldbergerOther · sold 80,000 at $6.80544K27% of stake
- Apr 10No planDaniel S GoldbergerOther · sold 16,072 at $6.0297K5.2% of stake
- Dec 4, 2025No planJoshua S. LevChief Financial Officer · sold 2,500 at $5.0513K10% of stake
- Dec 2, 2025Daniel S GoldbergerChief Executive Officer · bought 1,000 at $4.845K0.3% of stake
- Nov 12, 2025No planJoshua S. LevChief Financial Officer · sold 2,166 at $6.1813K8.4% of stake
- Aug 11, 2025Thomas J. ErricoDirector · bought 15,000 at $4.4767K5.6% of stake
- Aug 11, 2025Daniel S GoldbergerChief Executive Officer · bought 1,000 at $4.234K0.3% of stake
- May 23, 2025John P GandolfoDirector · bought 1,800 at $5.019K2.7% of stake
- May 12, 2025Thomas J. ErricoDirector · bought 10,000 at $4.7748K3.9% of stake
- Mar 17, 2025Daniel S GoldbergerChief Executive Officer · bought 1,000 at $8.599K0.3% of stake
- Mar 17, 2025Thomas J. ErricoDirector · bought 6,000 at $8.1049K2.4% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with ECOR
Spot a number that looks wrong? Check it in ECOR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ECOR
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.